At a glance
- Originator Muro Pharmaceutical; Viatris
- Class Amino acids; Antiasthmatics; Indoles
- Mechanism of Action Cyclophilin modulators; T cell activation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma; Rheumatoid arthritis
Most Recent Events
- 18 Jul 2006 No development reported - Preclinical for Asthma in Germany (unspecified route)
- 18 Jul 2006 No development reported - Preclinical for Asthma in USA (unspecified route)
- 18 Jul 2006 No development reported - Preclinical for Rheumatoid arthritis in Germany (unspecified route)